Baxter International Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 72/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 24.20.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Baxter International Inc's Score
Industry at a Glance
Industry Ranking
72 / 208
Overall Ranking
172 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
18
analysts
Hold
Current Rating
24.201
Target Price
+33.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Baxter International Inc Highlights
StrengthsRisks
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Undervalued
The company’s latest PE is -28.30, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 527.76M shares, increasing 0.01% quarter-over-quarter.
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Ticker SymbolBAX
CompanyBaxter International Inc
CEOHider (Andrew P)
Websitehttps://www.baxter.com/
FAQs
What is the current price of Baxter International Inc (BAX)?
The current price of Baxter International Inc (BAX) is 18.960.
What is the symbol of Baxter International Inc?
The ticker symbol of Baxter International Inc is BAX.
What is the 52-week high of Baxter International Inc?
The 52-week high of Baxter International Inc is 37.740.
What is the 52-week low of Baxter International Inc?
The 52-week low of Baxter International Inc is 17.400.
What is the market capitalization of Baxter International Inc?
The market capitalization of Baxter International Inc is 9.74B.
What is the net income of Baxter International Inc?
The net income of Baxter International Inc is -649.00M.
Is Baxter International Inc (BAX) currently rated as Buy, Hold, or Sell?
According to analysts, Baxter International Inc (BAX) has an overall rating of Hold, with a price target of 24.201.
What is the Earnings Per Share (EPS TTM) of Baxter International Inc (BAX)?
The Earnings Per Share (EPS TTM) of Baxter International Inc (BAX) is -0.670.